Overview
BCG-induced tuberculide is a rare cutaneous manifestation that can occur following Bacillus Calmette-Guérin (BCG) vaccination. It is a form of cutaneous tuberculosis that arises as a hypersensitivity reaction to the BCG organism or its components.
Diagnosis
Diagnosis is typically made clinically based on the characteristic skin lesions and a history of BCG vaccination.
Histopathological examination of skin biopsy may show granulomatous inflammation consistent with tuberculosis.
Cultures from skin lesions are often negative for Mycobacterium tuberculosis*.Management
Management is primarily supportive, as BCG-induced tuberculides are often self-limiting.
Topical or systemic corticosteroids may be used for symptomatic relief of inflammation.
In rare, severe cases, antituberculous therapy might be considered, although evidence is limited.Special Populations
Pediatrics: BCG vaccination is a universal policy in many countries, and BCG-induced tuberculides are a potential, albeit rare, complication in children 1. Outcomes of childhood TB, even in vaccinated populations, remain a concern 1.Key Recommendations
BCG vaccination is a universal policy in many countries, and while it aims to prevent severe forms of tuberculosis, rare complications like BCG-induced tuberculides can occur 1. (Evidence: Expert opinion)
Treatment outcomes for childhood tuberculosis, even in countries with universal BCG vaccination, remain a significant concern, with unfavorable outcomes reported in approximately 19.5% of cases 1. (Evidence: Moderate)
Efforts to address the global TB burden should be intensified, particularly targeting vulnerable populations such as children 1. (Evidence: Expert opinion)References
1 Dias JV, Varandas L, Gonçalves L, Kagina B. Outcomes of childhood TB in countries with a universal BCG vaccination policy. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2024. link